scholarly article | Q13442814 |
P356 | DOI | 10.1111/CEN.13264 |
P698 | PubMed publication ID | 27770475 |
P2093 | author name string | W F Young | |
G B Thompson | |||
Z Al-Hilli | |||
B L Clarke | |||
R Rodriguez-Gutierrez | |||
D Donegan | |||
N Singh Ospina | |||
P2860 | cites work | Inherited pancreatic endocrine tumor syndromes: advances in molecular pathogenesis, diagnosis, management, and controversies | Q24647838 |
Positional cloning of the gene for multiple endocrine neoplasia-type 1 | Q28307577 | ||
Epidemiology data on 108 MEN 1 patients from the GTE with isolated nonfunctioning tumors of the pancreas | Q31030383 | ||
Are patients with multiple endocrine neoplasia type I prone to premature death? | Q34064454 | ||
Genetic aspects of adenomatosis of endocrine glands | Q34234754 | ||
Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1). | Q34283436 | ||
Evaluation and management of adult hypoglycemic disorders: an Endocrine Society Clinical Practice Guideline | Q34905558 | ||
Morbidity and mortality of aggressive resection in patients with advanced neuroendocrine tumors | Q35197186 | ||
Surgery for gastroenteropancreatic tumours in multiple endocrine neoplasia type 1: review and personal experience | Q35987844 | ||
Causes of death and prognostic factors in multiple endocrine neoplasia type 1: a prospective study: comparison of 106 MEN1/Zollinger-Ellison syndrome patients with 1613 literature MEN1 patients with or without pancreatic endocrine tumors | Q37056120 | ||
Predicting prognosis in gastroentero-pancreatic neuroendocrine tumors: an overview and the value of Ki-67 immunostaining | Q37302846 | ||
Penetrance of functioning and nonfunctioning pancreatic neuroendocrine tumors in multiple endocrine neoplasia type 1 in the second decade of life. | Q38157760 | ||
Impact of Delay in Diagnosis in Outcomes in MEN1: Results From the Dutch MEN1 Study Group | Q40123801 | ||
Risk factors and causes of death in MEN1 disease. A GTE (Groupe d'Etude des Tumeurs Endocrines) cohort study among 758 patients | Q44301609 | ||
Presentation and outcome of pancreaticoduodenal endocrine tumors in multiple endocrine neoplasia type 1 syndrome | Q46191004 | ||
A follow-up study of patients with Zollinger-Ellison syndrome in the period 1966-2002: effects of surgical and medical treatments on long-term survival | Q46426134 | ||
Multiple endocrine neoplasia type 1 gene maps to chromosome 11 and is lost in insulinoma | Q48100816 | ||
Germline mutation profile of MEN1 in multiple endocrine neoplasia type 1: search for correlation between phenotype and the functional domains of the MEN1 protein. | Q53312970 | ||
Higher risk of aggressive pancreatic neuroendocrine tumors in MEN1 patients with MEN1 mutations affecting the CHES1 interacting MENIN domain. | Q54323177 | ||
KIT is an independent prognostic marker for pancreatic endocrine tumors: a finding derived from analysis of islet cell differentiation markers. | Q54474847 | ||
P433 | issue | 2 | |
P921 | main subject | multiple endocrine neoplasia | Q1553018 |
multiple endocrine neoplasia type 1 | Q3347154 | ||
P304 | page(s) | 199-206 | |
P577 | publication date | 2016-10-21 | |
P1433 | published in | Clinical Endocrinology | Q15762781 |
P1476 | title | Long-term outcomes in patients with multiple endocrine neoplasia type 1 and pancreaticoduodenal neuroendocrine tumours | |
P478 | volume | 86 |
Q48120158 | Heritable forms of primary hyperparathyroidism: a current perspective. |
Q91787051 | Multiple Endocrine Neoplasia Type 1: A Case Report With Review of Imaging Findings |
Q54638848 | Treatment of Pancreatic Neuroendocrine Tumors in Multiple Endocrine Neoplasia Type 1: Some Clarity But Continued Controversy. |
Search more.